In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cervelo Pharmaceuticals, Inc.

http://

Latest From Cervelo Pharmaceuticals, Inc.

CHPA Eyes Spanning Self-Care Space With Bridge To Device Sector

Many CHPA members also market medical devices "and the consumer side of medical devices is something they feel is underrepresented by other trade associations,” says trade group head Scott Melville. OTC drugs already have “a lot in common” with consumer medical devices, including that paying for neither typically is included in health insurance plans.

Prescription To OTC Switch Manufacturing

CHPA Eyes Spanning Self-Care Space With Bridge To Device Sector

Many CHPA members also market medical devices "and the consumer side of medical devices is something they feel is underrepresented by other trade associations,” says trade group head Scott Melville. OTC drugs already have “a lot in common” with consumer medical devices, including that paying for neither typically is included in health insurance plans.

Prescription To OTC Switch Manufacturing

Church & Dwight’s Acquisition Strategy Drives Management Shift

The firm reported third-quarter revenue growth of 4.6% to $842 million, including a 4.8% increase in the personal-care segment, and announced the close of recent feminine-health acquisitions. CFO Matthew Farrell adds COO to his title, a move expected to free up time for CEO James Craigie to focus on “chasing down” further acquisitions.

Church & Dwight’s Acquisition Strategy Drives Management Shift

The firm reports third-quarter revenues up 4.6% to $842 million, including 4.8% growth in the personal care segment to $247.7 million. CFO Matthew Farrell adds COO to his title, a move the firm and analysts expect to free up time for CEO James Craigie to focus on potential acquisitions.

Consumer United Kingdom
See All

Company Information

UsernamePublicRestriction

Register